Hjem › Lungesykdommer
Kliniske studier for Lungesykdommer rekrutterer i USA
57 studier for Lungesykdommer rekrutterer deltakere på steder over hele USA.
Byer med flest studier
- Houston, TX15 studier
- Boston, MA14 studier
- Durham, NC13 studier
- New York City, NY12 studier
- Pittsburgh, PA11 studier
- Nashville, TN10 studier
- Columbus, OH10 studier
- Los Angeles, CA10 studier
- Dallas, TX10 studier
- Washington, DC10 studier
- Miami, FL10 studier
- Ann Arbor, MI10 studier
- Chicago, IL9 studier
- Birmingham, AL9 studier
- Orlando, FL8 studier
- Baltimore, MD8 studier
- Philadelphia, PA8 studier
- Cincinnati, OH7 studier
- Atlanta, GA7 studier
- Tampa, FL7 studier
- Detroit, MI7 studier
- Jacksonville, FL7 studier
- Charleston, SC7 studier
- Seattle, WA7 studier
- Salt Lake City, UT6 studier
- St. Louis, MO6 studier
- Kansas City, KS6 studier
- Portland, OR5 studier
- Arlington, VA5 studier
- Louisville, KY5 studier
- Hialeah, FL5 studier
- San Francisco, CA5 studier
- Winston-Salem, NC5 studier
- Oklahoma City, OK5 studier
- Indianapolis, IN5 studier
- Richmond, VA4 studier
- Cleveland, OH4 studier
- Orange, CA4 studier
- Charlotte, NC4 studier
- Kansas City, MO4 studier
Etter delstat
- Alabama13 studier
- Arizona9 studier
- California30 studier
- Colorado12 studier
- District of Columbia6 studier
- Florida26 studier
- Georgia11 studier
- Hawaii3 studier
- Idaho3 studier
- Illinois16 studier
- Indiana5 studier
- Kansas9 studier
- Kentucky9 studier
- Louisiana5 studier
- Maryland13 studier
- Massachusetts15 studier
- Michigan17 studier
- Minnesota7 studier
- Missouri8 studier
- Nebraska4 studier
- Nevada6 studier
- New Jersey6 studier
- New Mexico3 studier
- New York16 studier
- North Carolina18 studier
- Ohio18 studier
- Oklahoma5 studier
- Oregon5 studier
- Pennsylvania21 studier
- Rhode Island4 studier
- South Carolina11 studier
- Tennessee15 studier
- Texas22 studier
- Utah7 studier
- Vermont4 studier
- Virginia10 studier
- Washington8 studier
- Wisconsin3 studier
Nylig oppdaterte studier
Offisiell studietekst (engelsk)
Study of the Disease Process of Lymphangioleiomyomatosis
RekruttererObservasjonsstudie
Alder 16 til 100 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT00001465Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 til 100 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT01730092Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05624450Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06765109A Study of COVID-19 Vaccine(s) in Children and Adults
RekruttererFase 3Frivillige helsepersonell ønskes velkommen
Alder 5 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07798648A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06679140Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07489066A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07013474A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
RekruttererFase 2
Alder 40 til 75 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07759245American Lung Association (ALA) Lung Health Cohort
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 25 til 35 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT04543461Study of Lung Proteins in Patients With Pneumonia
RekruttererObservasjonsstudie
Alder 3 til 99 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT00077909Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06128551A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
RekruttererFase 2
Alder 18 til 70 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06977581A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07407933Role of Genetic Factors in the Development of Lung Disease
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 2 til 90 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT00001532A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06572384A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06119581Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07059091Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
RekruttererFase 3
Alder 40 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07284602A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RekruttererFase 2
Alder 18 til 85 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07333183A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. sep. 2026 · NCT05967689A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
RekruttererFase 2
Alder 4 til 11 · Alle kjønn · Oppdatert 27. aug. 2026 · NCT07525375A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
Alder 18 til 60 · Alle kjønn · Oppdatert 27. aug. 2026 · NCT07745907Understanding New Cachexia Subtypes Through Observational Epidemiological Research
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT07776353A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 11. aug. 2026 · NCT07555483Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.